share_log

Benchmark Reiterates Buy on Imax, Maintains $22 Price Target

Benzinga ·  Apr 10 21:10

Benchmark analyst Mike Hickey reiterates Imax (NYSE:IMAX) with a Buy and maintains $22 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment